Related references
Note: Only part of the references are listed.Expression of phosphatase of regenerating liver-3 in squamous cell carcinoma of the cervix
Yaxi Ma et al.
MEDICAL ONCOLOGY (2011)
Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma
Akira Ooki et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Expression and Prognostic Value of PRL-3 in Human Intrahepatic Cholangiocarcinoma
Yijun Xu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue
Mahmut Yasen et al.
CANCER SCIENCE (2009)
Prognostic Significance of Phosphatase of Regenerating Liver-3 Expression in Ovarian Cancer
Tingting Ren et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer
Ni Da et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies:: an in situ hybridization study
U. A. Miskad et al.
VIRCHOWS ARCHIV (2007)
PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation
Fubo Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition
Haihe Wang et al.
CANCER RESEARCH (2007)
Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome
L. Wang et al.
ANNALS OF ONCOLOGY (2006)
Regulation of cell adhesion by protein-tyrosine phosphatases - I. Cell-matrix adhesion
Keith Burridge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Opportunities for targeted therapies in hepatocellular carcinoma
MB Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A long-term follow-up and management study of hepatocellular carcinoma patients surviving for 10 years or longer after curative hepatectomy
K Shimada et al.
CANCER (2005)
PRL-3 phosphatase is implicated in ovarian cancer growth
F Polato et al.
CLINICAL CANCER RESEARCH (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Catalytic domain of PRL-3 plays an essential role in tumor metastasis - Formation of PRL-3 tumors inside the blood vessels
K Guo et al.
CANCER BIOLOGY & THERAPY (2004)
Hepatocellular carcinoma: Current surgical management
TJ Song et al.
GASTROENTEROLOGY (2004)
Enhanced cell cycle progression and down regulation of p21Cip1/Waf1 by PRL tyrosine phosphatases
SR Werner et al.
CANCER LETTERS (2003)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
A phosphatase associated with metastasis of colorectal cancer
S Saha et al.
SCIENCE (2001)
Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling
WF Matter et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Prenylation-dependent association of protein-tyrosine phosphatases PRL-1,-2, and-3 with the plasma membrane and the early endosome
Q Zeng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, and patients' survival
K Endo et al.
HUMAN PATHOLOGY (2000)
Share Paper
